Damora Therapeutics Inc (DMRA) Annual Balance Sheets

Annual · GAAP · USD millions
Access DMRA quarterly Balance Sheets →
The balance sheet data below highlights changes in Damora Therapeutics Inc's financial position over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent257.62
Combined Cash+Investments Total (filer-reported)257.60
Marketable Securities0.00
Cash & Short-term Investments257.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.80
Total Current Assets260.42
Equipment/Property/Plant Net0.04
Long-term investments0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset0.07
Total Assets260.53
Liabilities
Accounts Payable, Current AC0.44
Accrued Liabilities And Other Liabilities2.40
Other Liabilities, Current17.22
Total Current Liabilities20.07
Total Long-term Debt0.00
Other liabilities, Noncurrent0.08
OperatingLeaseLiabilityNoncurrent0.05
Total Liabilities20.15
Stockholders' Equity
Additional Paid In Capital Common Stock310.69
Retained Earnings / Accumulated Deficit-487.36
Other Equity298.09
Common Stockholder's Equity121.42
Preferred Stockholder's Equity117.62
Non-controlling interests & other1.34
Total Stockholder's Equity240.38
Liabilities & Stockholder's Equity260.53
4 historic quarters locked

Sign in to unlock the full Damora Therapeutics Inc balance sheet history.

About Damora Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-115922

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License